Ananda Developments PLC - London-based medical cannabis company - Says its wholly owned subsidiary MRX Medical Ltd, has filed four patent applications with the UK government's Intellectual Property Office.

"The applications cover three cannabinoid formulations known as MRX1, MRX2 and its most recently invented formulation MRX3. These formulations are being developed as cannabidiol-based medicines for the treatment of a number of complex inflammatory indications which are unmet by existing treatments. The fourth application covers a proprietary method for formulating these products," it says.

Current stock price: 0.622 pence per share

12-month change: down 4.3%

By Sophie Rose, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.